A Congressional Budget Office report critical of the Medicare fee-for-service demonstration projects in disease management, care coordination, and value-based payments has received mixed reviews from stakeholders who acknowledge the report's significance while contending that it contains no surprises for the healthcare industry.
Meanwhile, officials at the Centers for Medicare & Medicaid Services, which oversees the demonstration projects, have remained almost silent. CMS provided only a short e-mail statement to HealthLeaders Media on Friday night.
The 30-page CBO report, released last week, reviews the independent evaluations of 10 major demonstration projects—six in disease management and care coordination, and four in value-based payments. According to the CBO, "the evaluations show that most programs have not reduced Medicare spending."
Among the mixed bag of findings: